Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U24100DL2014PTC264559 Incorporated 06 February 2014 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹93.78 Cr
▲ 40.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.84 Cr
Issued & subscribed
Open charges
₹30.55 Cr
Satisfied ₹1.95 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
78
Latest available

About Daxin Pharmaceuticals Private Limited

Data last updated: 05 January 2026

Daxin Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 February 2014, the company has been in operation for over 12 years.

Registered with ROC Delhi under CIN U24100DL2014PTC264559.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.84 Cr. It is led by directors Sheela Jha and Nikhil Kumar Jha.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Office No – 204 205 2Nd Floor, Apra Dwarka Plaza – I Plot No – 21 Sector – 10 Dwarka, New Delhi, Delhi, India – 110075.

As per the financials filed for FY 2025, the company reported a revenue of ₹93.78 Cr, a growth of 40% compared to the previous year.

The company has a workforce of approximately 78 employees as per the latest available data.

The company is associated with 1 brand - Daxin Pharma. As per MCA filings, the company has open charges of ₹30.55 Cr and satisfied charges of ₹1.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daxinpharma.in.

Company Details of Daxin Pharmaceuticals Private Limited
CIN U24100DL2014PTC264559
Registration Number 264559
Incorporation Date 06 February 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    Office No – 204 205 2Nd Floor, Apra Dwarka Plaza – I Plot No – 21 Sector – 10 Dwarka, New Delhi, Delhi, India – 110075
  • Industry
    Pharma, Drug Formulation & Development
Company report
Daxin Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Daxin Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Daxin Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited operates one associated brand: Daxin Pharma. These brands represent Daxin Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Produces pharmaceutical tablets, capsules, liquids, and injections for worldwide healthcare markets. daxinpharma.in

Competitors & Alternatives of Daxin Pharmaceuticals Private Limited

Brands and companies operating in the same space as Daxin Pharmaceuticals Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited is engaged in principal business activities including trade and manufacturing, with detailed activities including wholesale trading, chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Daxin Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited is audited by KAUSHAL ANKITA & ASSOCIATES for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
KAUSHAL ANKITA & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Daxin Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited is currently managed by 2 directors, with 1 former director having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sheela Jha Director 06 Feb 2014 12 Years 6 Months Current
Nikhil Kumar Jha Director 16 Feb 2014 12 Years 5 Months Current

Financials of Daxin Pharmaceuticals Private Limited FY 2024 filings available

Daxin Pharmaceuticals Private Limited reported revenue of ₹93.78 Cr (up 40.00% YoY) for FY 2025.

Revenue · FY 2025
₹93.78 Cr ▲ 40.00%
Premium access

Ten-year financial statements for Daxin Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Daxin Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Daxin Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Daxin Pharmaceuticals Private Limited

Open charges
₹30.55 Cr
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Others₹30.55 Cr
Latest charge details
DateLenderAmountStatus
20 Apr 2024 Others ₹32.97 Lakh Open
25 Nov 2021 Others ₹1.05 Cr Open
20 Nov 2020 Others ₹29.17 Cr Open
30 May 2015 Others ₹1.95 Cr Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited has a workforce of 78 employees as of Mar 24, 2025.

Employee count
78
Active EPFO establishments
2
Employee growth
-43.07%
Premium access

Employee and EPFO history for Daxin Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Daxin Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Daxin Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Daxin Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Daxin Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Daxin Pharmaceuticals Private Limited

Premium access

MSME payment history for Daxin Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Daxin Pharmaceuticals Private Limited

Premium access

Corporate group structure for Daxin Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Daxin Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Daxin Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Daxin Pharmaceuticals Private Limited

Charges
03 Jun 2025
A charge with Others of Rs. 29.17 Cr registered on 20 Nov 2020 with Charge ID 100402828 was modified on 03 Jun 2025.
Activity
30 Sep 2024
Daxin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
20 Apr 2024
A charge with Others amounted to Rs. 0.33 Cr with Charge ID 100913441 was registered on 20 Apr 2024.
Activity
31 Mar 2024
Daxin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
04 Jan 2024
A charge registered on 30 May 2015 via Charge ID 10578019 with Others was fully satisfied on 04 Jan 2024.
Charges
25 Nov 2021
A charge with Others amounted to Rs. 1.05 Cr with Charge ID 100504861 was registered on 25 Nov 2021.

Frequently Asked Questions about Daxin Pharmaceuticals Private Limited

Daxin Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 06 February 2014 (12+ years old) and is registered under CIN U24100DL2014PTC264559. The company has 78 employees.

Daxin Pharmaceuticals Private Limited reported revenue of ₹93.78 Cr for FY 2025 (up 40.00% YoY).

The current directors of Daxin Pharmaceuticals Private Limited are:

The primary industry of Daxin Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Daxin Pharmaceuticals Private Limited can be reached at the registered office: Office No – 204 205 2Nd Floor, Apra Dwarka Plaza – I Plot No – 21 Sector – 10 Dwarka, New Delhi, Delhi, India – 110075, or through the website daxinpharma.in.

The authorised capital is ₹10 Cr, and the paid-up capital is ₹9.84 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available